At the heart of the technology behind his connected device is the interlinking of diverse sensors and the label with an integrated NFC chip which Schreiner MediPharm adapted to YpsoMate®. The NFC chip identifies and authenticates the medicine and checks its expiration date. According to the prescribed therapy, the patient can be guided in real time through the injection process or feedback on the correct administration of the medicine can be transmitted. It is also possible to store the entire injection history in detail—from the injection time and its success through to the patient’s well-being—and to share it with other stakeholders. The attending physician, for instance, is then able to use this information to adjust the continuing therapy plan.
The integration of NFC technology, which has to ensure reliable reading, in a very small space posed the primary challenge in this label development. Subsequent ease of processing was another specified objective. The result of the development cooperation with Ypsomed is an innovative solution for pharmaceutical manufacturers who are now able to provide patients with the SmartPilot™ as a valuable tool supporting them in their self-medication.